生物製剤医薬品開発の世界市場 2020年

• 英文タイトル：Global Biologics Drug Development Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201113695 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、生物製剤医薬品開発の世界市場を調査対象にし、生物製剤医薬品開発の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（臨床製造、製剤開発、バイオアッセイ開発、分析サービス）、用途別分析（社内、アウトソーシング、製薬過剰）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Abbvie、Sanofi、Charles River Laboratories、Allergan、Amgen、Boehringer Ingelheim、Lonza Group、Catalent ・企業別売上、市場シェア ・生物製剤医薬品開発の地域別市場分析 ・生物製剤医薬品開発の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・生物製剤医薬品開発のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・生物製剤医薬品開発のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・生物製剤医薬品開発の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・生物製剤医薬品開発の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・生物製剤医薬品開発の種類別市場規模2015-2020：臨床製造、製剤開発、バイオアッセイ開発、分析サービス ・生物製剤医薬品開発の用途別市場規模2015-2020：社内、アウトソーシング、製薬過剰 ・生物製剤医薬品開発の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Biologics Drug Development market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Biologics Drug Development market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Biologics Drug Development market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Biologics Drug Development market has been segmented into:
Clinical Manufacturing
Formulation Development
Bioassay Development
Analytical Services

By Application, Biologics Drug Development has been segmented into:
In-House
Outsource
Pharma Excess

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biologics Drug Development market presented in the report. This section sheds light on the sales growth of different regional and country-level Biologics Drug Development markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biologics Drug Development market.

The report offers in-depth assessment of the growth and other aspects of the Biologics Drug Development market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Biologics Drug Development Market Share Analysis
Biologics Drug Development competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biologics Drug Development sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biologics Drug Development sales, revenue and market share for each player covered in this report.

The major players covered in Biologics Drug Development are:
Abbvie
Sanofi
Charles River Laboratories
Allergan
Amgen
Boehringer Ingelheim
Lonza Group
Catalent

レポート目次

---

1 Biologics Drug Development Market Overview
1.1 Product Overview and Scope of Biologics Drug Development
1.2 Classification of Biologics Drug Development by Type
1.2.1 Global Biologics Drug Development Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biologics Drug Development Revenue Market Share by Type in 2019
1.2.3 Clinical Manufacturing
1.2.4 Formulation Development
1.2.5 Bioassay Development
1.2.6 Analytical Services
1.3 Global Biologics Drug Development Market by Application
1.3.1 Overview: Global Biologics Drug Development Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 In-House
1.3.3 Outsource
1.3.4 Pharma Excess
1.4 Global Biologics Drug Development Market by Regions
1.4.1 Global Biologics Drug Development Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biologics Drug Development (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biologics Drug Development Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biologics Drug Development Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologics Drug Development Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biologics Drug Development Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologics Drug Development Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbvie
2.1.1 Abbvie Details
2.1.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbvie SWOT Analysis
2.1.4 Abbvie Product and Services
2.1.5 Abbvie Biologics Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Biologics Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.3 Charles River Laboratories
2.3.1 Charles River Laboratories Details
2.3.2 Charles River Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Charles River Laboratories SWOT Analysis
2.3.4 Charles River Laboratories Product and Services
2.3.5 Charles River Laboratories Biologics Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Allergan SWOT Analysis
2.4.4 Allergan Product and Services
2.4.5 Allergan Biologics Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Amgen SWOT Analysis
2.5.4 Amgen Product and Services
2.5.5 Amgen Biologics Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim SWOT Analysis
2.6.4 Boehringer Ingelheim Product and Services
2.6.5 Boehringer Ingelheim Biologics Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.7 Lonza Group
2.7.1 Lonza Group Details
2.7.2 Lonza Group Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Lonza Group SWOT Analysis
2.7.4 Lonza Group Product and Services
2.7.5 Lonza Group Biologics Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.8 Catalent
2.8.1 Catalent Details
2.8.2 Catalent Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Catalent SWOT Analysis
2.8.4 Catalent Product and Services
2.8.5 Catalent Biologics Drug Development Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biologics Drug Development Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biologics Drug Development Players Market Share
3.2.2 Top 10 Biologics Drug Development Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biologics Drug Development Revenue and Market Share by Regions
4.2 North America Biologics Drug Development Revenue and Growth Rate (2015-2020)
4.3 Europe Biologics Drug Development Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biologics Drug Development Revenue and Growth Rate (2015-2020)
4.5 South America Biologics Drug Development Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biologics Drug Development Revenue and Growth Rate (2015-2020)
5 North America Biologics Drug Development Revenue by Countries
5.1 North America Biologics Drug Development Revenue by Countries (2015-2020)
5.2 USA Biologics Drug Development Revenue and Growth Rate (2015-2020)
5.3 Canada Biologics Drug Development Revenue and Growth Rate (2015-2020)
5.4 Mexico Biologics Drug Development Revenue and Growth Rate (2015-2020)
6 Europe Biologics Drug Development Revenue by Countries
6.1 Europe Biologics Drug Development Revenue by Countries (2015-2020)
6.2 Germany Biologics Drug Development Revenue and Growth Rate (2015-2020)
6.3 UK Biologics Drug Development Revenue and Growth Rate (2015-2020)
6.4 France Biologics Drug Development Revenue and Growth Rate (2015-2020)
6.5 Russia Biologics Drug Development Revenue and Growth Rate (2015-2020)
6.6 Italy Biologics Drug Development Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biologics Drug Development Revenue by Countries
7.1 Asia-Pacific Biologics Drug Development Revenue by Countries (2015-2020)
7.2 China Biologics Drug Development Revenue and Growth Rate (2015-2020)
7.3 Japan Biologics Drug Development Revenue and Growth Rate (2015-2020)
7.4 Korea Biologics Drug Development Revenue and Growth Rate (2015-2020)
7.5 India Biologics Drug Development Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biologics Drug Development Revenue and Growth Rate (2015-2020)
8 South America Biologics Drug Development Revenue by Countries
8.1 South America Biologics Drug Development Revenue by Countries (2015-2020)
8.2 Brazil Biologics Drug Development Revenue and Growth Rate (2015-2020)
8.3 Argentina Biologics Drug Development Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biologics Drug Development by Countries
9.1 Middle East & Africa Biologics Drug Development Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biologics Drug Development Revenue and Growth Rate (2015-2020)
9.3 UAE Biologics Drug Development Revenue and Growth Rate (2015-2020)
9.4 Egypt Biologics Drug Development Revenue and Growth Rate (2015-2020)
9.5 South Africa Biologics Drug Development Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biologics Drug Development Revenue and Market Share by Type (2015-2020)
10.2 Global Biologics Drug Development Market Forecast by Type (2019-2024)
10.3 Clinical Manufacturing Revenue Growth Rate (2015-2025)
10.4 Formulation Development Revenue Growth Rate (2015-2025)
10.5 Bioassay Development Revenue Growth Rate (2015-2025)
10.6 Analytical Services Revenue Growth Rate (2015-2025)
11 Global Biologics Drug Development Market Segment by Application
11.1 Global Biologics Drug Development Revenue Market Share by Application (2015-2020)
11.2 Biologics Drug Development Market Forecast by Application (2019-2024)
11.3 In-House Revenue Growth (2015-2020)
11.4 Outsource Revenue Growth (2015-2020)
11.5 Pharma Excess Revenue Growth (2015-2020)
12 Global Biologics Drug Development Market Size Forecast (2021-2025)
12.1 Global Biologics Drug Development Market Size Forecast (2021-2025)
12.2 Global Biologics Drug Development Market Forecast by Regions (2021-2025)
12.3 North America Biologics Drug Development Revenue Market Forecast (2021-2025)
12.4 Europe Biologics Drug Development Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biologics Drug Development Revenue Market Forecast (2021-2025)
12.6 South America Biologics Drug Development Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biologics Drug Development Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Biologics Drug Development Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biologics Drug Development by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biologics Drug Development Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biologics Drug Development Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbvie Corporate Information, Location and Competitors
Table 6. Abbvie Biologics Drug Development Major Business
Table 7. Abbvie Biologics Drug Development Total Revenue (USD Million) (2017-2018)
Table 8. Abbvie SWOT Analysis
Table 9. Abbvie Biologics Drug Development Product and Solutions
Table 10. Abbvie Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sanofi Corporate Information, Location and Competitors
Table 12. Sanofi Biologics Drug Development Major Business
Table 13. Sanofi Biologics Drug Development Total Revenue (USD Million) (2018-2019)
Table 14. Sanofi SWOT Analysis
Table 15. Sanofi Biologics Drug Development Product and Solutions
Table 16. Sanofi Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Charles River Laboratories Corporate Information, Location and Competitors
Table 18. Charles River Laboratories Biologics Drug Development Major Business
Table 19. Charles River Laboratories Biologics Drug Development Total Revenue (USD Million) (2017-2018)
Table 20. Charles River Laboratories SWOT Analysis
Table 21. Charles River Laboratories Biologics Drug Development Product and Solutions
Table 22. Charles River Laboratories Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Allergan Corporate Information, Location and Competitors
Table 24. Allergan Biologics Drug Development Major Business
Table 25. Allergan Biologics Drug Development Total Revenue (USD Million) (2017-2018)
Table 26. Allergan SWOT Analysis
Table 27. Allergan Biologics Drug Development Product and Solutions
Table 28. Allergan Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Amgen Corporate Information, Location and Competitors
Table 30. Amgen Biologics Drug Development Major Business
Table 31. Amgen Biologics Drug Development Total Revenue (USD Million) (2017-2018)
Table 32. Amgen SWOT Analysis
Table 33. Amgen Biologics Drug Development Product and Solutions
Table 34. Amgen Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 36. Boehringer Ingelheim Biologics Drug Development Major Business
Table 37. Boehringer Ingelheim Biologics Drug Development Total Revenue (USD Million) (2017-2018)
Table 38. Boehringer Ingelheim SWOT Analysis
Table 39. Boehringer Ingelheim Biologics Drug Development Product and Solutions
Table 40. Boehringer Ingelheim Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Lonza Group Corporate Information, Location and Competitors
Table 42. Lonza Group Biologics Drug Development Major Business
Table 43. Lonza Group Biologics Drug Development Total Revenue (USD Million) (2017-2018)
Table 44. Lonza Group SWOT Analysis
Table 45. Lonza Group Biologics Drug Development Product and Solutions
Table 46. Lonza Group Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Catalent Corporate Information, Location and Competitors
Table 48. Catalent Biologics Drug Development Major Business
Table 49. Catalent Biologics Drug Development Total Revenue (USD Million) (2017-2018)
Table 50. Catalent SWOT Analysis
Table 51. Catalent Biologics Drug Development Product and Solutions
Table 52. Catalent Biologics Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Biologics Drug Development Revenue (Million USD) by Players (2015-2020)
Table 54. Global Biologics Drug Development Revenue Share by Players (2015-2020)
Table 55. Global Biologics Drug Development Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Biologics Drug Development Revenue Market Share by Regions (2015-2020)
Table 57. North America Biologics Drug Development Revenue by Countries (2015-2020)
Table 58. North America Biologics Drug Development Revenue Market Share by Countries (2015-2020)
Table 59. Europe Biologics Drug Development Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Biologics Drug Development Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Biologics Drug Development Revenue by Countries (2015-2020)
Table 62. South America Biologics Drug Development Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Biologics Drug Development Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Biologics Drug Development Revenue Market Share by Countries (2015-2020)
Table 65. Global Biologics Drug Development Revenue (Million USD) by Type (2015-2020)
Table 66. Global Biologics Drug Development Revenue Share by Type (2015-2020)
Table 67. Global Biologics Drug Development Revenue Forecast by Type (2021-2025)
Table 68. Global Biologics Drug Development Revenue by Application (2015-2020)
Table 69. Global Biologics Drug Development Revenue Share by Application (2015-2020)
Table 70. Global Biologics Drug Development Revenue Forecast by Application (2021-2025)
Table 71. Global Biologics Drug Development Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biologics Drug Development Picture
Figure 2. Global Biologics Drug Development Revenue Market Share by Type in 2019
Figure 3. Clinical Manufacturing Picture
Figure 4. Formulation Development Picture
Figure 5. Bioassay Development Picture
Figure 6. Analytical Services Picture
Figure 7. Biologics Drug Development Revenue Market Share by Application in 2019
Figure 8. In-House Picture
Figure 9. Outsource Picture
Figure 10. Pharma Excess Picture
Figure 11. Global Biologics Drug Development Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Biologics Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Biologics Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Biologics Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Biologics Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Biologics Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Biologics Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Biologics Drug Development Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Biologics Drug Development Revenue Market Share in 2019
Figure 20. Global Top 10 Players Biologics Drug Development Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Biologics Drug Development Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Biologics Drug Development Revenue Market Share by Regions (2015-2020)
Figure 24. Global Biologics Drug Development Revenue Market Share by Regions in 2018
Figure 25. North America Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 26. Europe Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 28. South America Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 30. North America Biologics Drug Development Revenue Market Share by Countries (2015-2020)
Figure 31. North America Biologics Drug Development Revenue Market Share by Countries in 2019
Figure 32. USA Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 33. Canada Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 35. Europe Biologics Drug Development Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Biologics Drug Development Revenue Market Share by Countries in 2019
Figure 37. Germany Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 38. UK Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 39. France Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 40. Russia Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 41. Italy Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Biologics Drug Development Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Biologics Drug Development Revenue Market Share by Countries in 2019
Figure 44. China Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 45. Japan Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 46. Korea Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 47. India Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 49. South America Biologics Drug Development Revenue Market Share by Countries (2015-2020)
Figure 50. South America Biologics Drug Development Revenue Market Share by Countries in 2019
Figure 51. Brazil Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Biologics Drug Development Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Biologics Drug Development Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 56. UAE Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Biologics Drug Development Revenue and Growth Rate (2015-2020)
Figure 59. Global Biologics Drug Development Revenue Share by Type (2015-2020)
Figure 60. Global Biologics Drug Development Revenue Share by Type in 2019
Figure 61. Global Biologics Drug Development Market Share Forecast by Type (2021-2025)
Figure 62. Global Clinical Manufacturing Revenue Growth Rate (2015-2020)
Figure 63. Global Formulation Development Revenue Growth Rate (2015-2020)
Figure 64. Global Bioassay Development Revenue Growth Rate (2015-2020)
Figure 65. Global Analytical Services Revenue Growth Rate (2015-2020)
Figure 66. Global Biologics Drug Development Revenue Share by Application (2015-2020)
Figure 67. Global Biologics Drug Development Revenue Share by Application in 2019
Figure 68. Global Biologics Drug Development Market Share Forecast by Application (2021-2025)
Figure 69. Global In-House Revenue Growth Rate (2015-2020)
Figure 70. Global Outsource Revenue Growth Rate (2015-2020)
Figure 71. Global Pharma Excess Revenue Growth Rate (2015-2020)
Figure 72. Global Biologics Drug Development Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Biologics Drug Development Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Biologics Drug Development Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Biologics Drug Development Revenue Market Forecast (2021-2025)
Figure 76. Europe Biologics Drug Development Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Biologics Drug Development Revenue Market Forecast (2021-2025)
Figure 78. South America Biologics Drug Development Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Biologics Drug Development Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---